Cargando…

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1

Acute myeloid leukemia (AML), a malignant disorder of hemopoietic stem cells. AML can escape immunosurveillance of natural killer (NK) by gene mutation, fusions, and epigenetic modification, while the mechanism is not clearly understood. Here we show that the expression of Intercellular adhesion mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yang, Chen, Jinghong, Wang, Jia, Guan, Wei, Wang, Mengzhen, Zhang, Linlin, Wang, Zhiding, Wang, Lixin, Yu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548470/ https://www.ncbi.nlm.nih.gov/pubmed/34722306 http://dx.doi.org/10.3389/fonc.2021.751834

Ejemplares similares

One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
por: Wang, Zhiding, et al.
Publicado: (2021)

MR1-restricted T cells: the new dawn of cancer immunotherapy
por: Wang, Zhiding, et al.
Publicado: (2020)

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
por: Zhong, Fang-Min, et al.
Publicado: (2022)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
por: Radpour, Ramin, et al.
Publicado: (2021)

Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia
por: van Gils, Noortje, et al.
Publicado: (2021)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
por: Sun, Younguk, et al.
Publicado: (2018)

Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
por: Dhall, Abhinav, et al.
Publicado: (2019)

Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
por: Shang, Yufeng, et al.
Publicado: (2019)

The role of natural killer cells in chronic myeloid leukemia
por: Danier, Anna Carolyna Araújo, et al.
Publicado: (2011)

Natural killer group 2D receptor and its ligands in cancer immune escape
por: Duan, Shixin, et al.
Publicado: (2019)

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
por: Lopez, Diana C., et al.
Publicado: (2022)

Natural killer cell-based immunotherapy for acute myeloid leukemia
por: Xu, Jing, et al.
Publicado: (2020)

Contribution of natural killer cells in innate immunity against colorectal cancer
por: Ghazvinian, Zeinab, et al.
Publicado: (2023)

Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis
por: Al-Bulushi, Fatma, et al.
Publicado: (2022)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
por: Li, Jessica, et al.
Publicado: (2020)

Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation
por: Que, Yimei, et al.
Publicado: (2021)

Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia
por: Jamal, Esraa, et al.
Publicado: (2020)

A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
por: Mu, Hui, et al.
Publicado: (2021)

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
por: Liu, Lu, et al.
Publicado: (2020)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
por: Lamble, Adam J., et al.
Publicado: (2018)

miR-181d/RBP2/NF-κB p65 Feedback Regulation Promotes Chronic Myeloid Leukemia Blast Crisis
por: Zhou, Minran, et al.
Publicado: (2021)

Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
por: Ding, Yi, et al.
Publicado: (2022)

Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48
por: Zhang, Tianzhuo, et al.
Publicado: (2022)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis
por: Gómez-Llobell, Marina, et al.
Publicado: (2022)

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia
por: Yin, Jia, et al.
Publicado: (2021)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
por: Lu, Rui, et al.
Publicado: (2017)

Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia
por: Cheng, Yaqi, et al.
Publicado: (2021)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
por: Jiang, Wen, et al.
Publicado: (2022)

Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma
por: Hai, Tao, et al.
Publicado: (2023)

Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia
por: Bai, Shenrui, et al.
Publicado: (2023)

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models
por: Rettinger, Eva, et al.
Publicado: (2012)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ru9jrc5tae4o9vbu7ni86ee3a